Aptevo Therapeutics Inc.

APVONASDAQHealthcare● Active

$4.89

+$0.17(+3.60%)

Market Cap$10693731

P/E Ratio—

52W High$235.98

52W Low$3.8

Avg Volume57K

Open$4.80

Beta1.69

Net Income Financials Revenue

Aptevo Therapeutics Inc. (APVO) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

APVO · net income · updated Jun 9, 2026

Core profitability metrics

APVO · net income · margin · TTM · CAGR

Net income was −$26.0M for FY2025 (fiscal year ending 2025-12-31), down 7.6% year-over-year. Net profit margin was —. Based on available data, Aptevo Therapeutics Inc. has been profitable since at least 2017.

FY2025 Net Income−$26.0M▼ -7.6% YoY

Trailing 12M (TTM)−$26.3Mtrailing 4 quarters sum

Net Profit Margin——

YoY Change-7.6%—

5-Year CAGRN/AN/A — contains loss years

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 9, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %★ First Profit: 2017

▸ FMP /income-statement · Annual · APVO net income history · APVO profit margin

Annual net income data

APVO · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2025Loss−$26.0M▼ 7.6%—$0

FY2024Loss−$24.1M▼ 38.6%—$0

FY2023Loss−$17.4M▼ 316.9%—$0

FY2022$8.0M▲ +128.2%257.8%$3.1M

FY2021Loss−$28.5M▼ 60.3%-231.5%$12.3M

Net income vs peers (Healthcare)

APVO vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

Aptevo Therapeutics Inc.YOU

APVO

−$26.0M-7.6%—

Loss

Eli Lilly and Company

LLY

$20.64B+94.9%31.7%

77%

UnitedHealth Group Incorporated

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Aptevo Therapeutics Inc. (APVO) reported net income of −$26.0M for FY2025 (fiscal year ending 2025-12-31), down 7.6% year-over-year. The net profit margin was — — meaning the company kept $— of every dollar of revenue as profit.

Based on available data, Aptevo Therapeutics Inc. has been profitable since at least 2017. Net income reached a peak of $8.0M in FY2022. Data available for 13 fiscal years.

Aptevo Therapeutics Inc.'s net profit margin was — for FY2025, based on the latest annual results.

Investors sometimes search for "Aptevo Therapeutics Inc. net worth" — the company's market capitalization is a separate figure from APVO net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

APVO net income · 4 questions

Aptevo Therapeutics Inc. is not currently profitable on an annual basis. The company reported a net loss of $26.0M for FY2025.

is APVO profitabledoes APVO make a profitAPVO profitabilityAPVO profitable company

▸ Source: FMP /income-statement · GAAP · Aptevo Therapeutics Inc. · Aptevo Therapeutics Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026